Trial intelligence / Profile preview

Intraarticular glucocorticoid injection after arthroscopic rotator cuff repair

ChiCTR2500102187Phase 4Not yet recruiting

Sponsor
West China Hospital of Sichuan University
Start
May 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of betamethasone dipropionate + betamethasone sodium phosphate in rotator cuff tear (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Rotator cuff retear rate. Planned start May 2025; status: not yet recruiting.

02

Drugs

betamethasone dipropionate + betamethasone sodium phosphate
03

Conditions

rotator cuff tear

Beyond the preview

Go deeper on ChiCTR2500102187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500102187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call